FBInvestor
Stocks / Tempest Therapeutics Inc
Institutional Ownership

Tempest Therapeutics Inc

CUSIP 87978U108COMTPSTQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon